...
首页> 外文期刊>Biomaterials >Chemical gas-generating nanoparticles for tumor-targeted ultrasound imaging and ultrasound-triggered drug delivery
【24h】

Chemical gas-generating nanoparticles for tumor-targeted ultrasound imaging and ultrasound-triggered drug delivery

机译:用于肿瘤靶向超声成像和超声触发药物递送的化学气体生成纳米颗粒

获取原文
获取原文并翻译 | 示例

摘要

Although there is great versatility of ultrasound (US) technologies in the real clinical field, one main technical challenge is the compromising of high quality of echo properties and size engineering of ultrasound contrast agents (UCAs); a high echo property is offset by reducing particle size. Herein, a new strategy for overcoming the dilemma by devising chemical gas (CO2) generating carbonate copolymer nanoparticles (Gas-NPs), which are clearly distinguished from the conventional gas-encapsulated micro sized UCAs. More importantly, Gas-NPs could be readily engineered to strengthen the desirable in vivo physicochemical properties for nano-sized drug carriers with higher tumor targeting ability, as well as the high quality of echo properties for tumor-targeted US imaging. In tumor-bearing mice, anticancer drug-loaded Gas-NPs showed the desirable theranostic functions for US-triggered drug delivery, even after i.v. injection. In this regard, and as demonstrated in the aforementioned study, our technology could serve a highly effective platform in building theranostic UCAs with great sophistication and therapeutic applicability in tumor-targeted US imaging and US-triggered drug delivery. (C) 2016 Elsevier Ltd. All rights reserved.
机译:虽然超声(美国)技术在真正的临床领域有很大的多功能性,但一个主要的技术挑战是超声造影剂的高质量和大小工程(UCAS)的高质量高质量和尺寸工程;通过降低粒度,高回声特性偏离。这里,通过设计生成碳酸盐共聚物纳米粒子(气体-NP)的化学气体(CO2)来克服困境的新策略,这些策略与常规的气囊包封的微尺寸UCAS明显区别。更重要的是,可以容易地改造气体NP以加强具有更高肿瘤靶向能力的纳米药物载体的体内物理化学性质的所需,以及肿瘤靶向美国成像的高质量回声性能。在携带肿瘤的小鼠中,抗癌药物载体的气体NPS表明,即使在I.v之后,也表明了美国触发的药物递送的理想治疗功能。注射。在这方面,如上所述,我们的技术可以在肿瘤针对美国成像和美国触发的药物递送方面具有良好的复杂性和治疗性的高效平台。 (c)2016 Elsevier Ltd.保留所有权利。

著录项

  • 来源
    《Biomaterials》 |2016年第null期|共14页
  • 作者单位

    Korea Inst Sci &

    Technol Biomed Res Inst Ctr Theragnosis 39-1 Hawolgok Dong Seoul 136791 South;

    Korea Inst Sci &

    Technol Biomed Res Inst Ctr Theragnosis 39-1 Hawolgok Dong Seoul 136791 South;

    Korea Inst Sci &

    Technol Biomed Res Inst Ctr Theragnosis 39-1 Hawolgok Dong Seoul 136791 South;

    Korea Inst Sci &

    Technol Biomed Res Inst Ctr Theragnosis 39-1 Hawolgok Dong Seoul 136791 South;

    Korea Inst Sci &

    Technol Biomed Res Inst Ctr Theragnosis 39-1 Hawolgok Dong Seoul 136791 South;

    Korea Inst Sci &

    Technol Biomed Res Inst Ctr Theragnosis 39-1 Hawolgok Dong Seoul 136791 South;

    Korea Inst Sci &

    Technol Biomed Res Inst Ctr Theragnosis 39-1 Hawolgok Dong Seoul 136791 South;

    Seoul Natl Univ Hosp Dept Radiol 101 Daehangno Seoul 110744 South Korea;

    Seoul Natl Univ Hosp Dept Radiol 101 Daehangno Seoul 110744 South Korea;

    Sungkyunkwan Univ Sch Chem Engn Suwon 440746 South Korea;

    Korea Inst Sci &

    Technol Biomed Res Inst Ctr Theragnosis 39-1 Hawolgok Dong Seoul 136791 South;

    Korea Inst Sci &

    Technol Biomed Res Inst Ctr Theragnosis 39-1 Hawolgok Dong Seoul 136791 South;

    Purdue Univ Dept Biomed Engn &

    Pharmaceut W Lafayette IN 47960 USA;

    Korea Inst Sci &

    Technol Biomed Res Inst Ctr Theragnosis 39-1 Hawolgok Dong Seoul 136791 South;

    Korea Inst Sci &

    Technol Biomed Res Inst Ctr Theragnosis 39-1 Hawolgok Dong Seoul 136791 South;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物医学工程;
  • 关键词

    Ultrasound (US) imaging; Ultrasound contrast agent (UCA); Chemical gas-generating nanoparticle; Tumor targeting; Drug delivery;

    机译:超声(美国)成像;超声造影剂(UCA);化学气体产生纳米粒子;肿瘤靶向;药物递送;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号